Puma Biotechnology | PBYI - DETTE





DETTE Changement Date
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amgen USD 54.6B 17M 2025-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Exelixis USD 169.54M 3.5M 2026-03
Gilead Sciences USD 24.94B 5M 2025-12
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Incyte USD 39.43M 982K 2026-03
MacroGenics USD 36.51M 500K 2026-03
Moderna USD 1.31B 571M 2025-12
Novartis USD 47B 11.62B 2026-03
Pfizer USD 63.73B 231M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Takeda JPY 4.85T 208B 2025-12
TG Therapeutics USD 253.71M 8.37M 2025-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 1.99B 44M 2026-03